Venture Life Group Plc (LON:VLG) yesterday was the subject of a new research report issued by Panmure Gordon in which it was reiterated as “Buy” by analysts at the firm. They now have GBX 220 ($2.87) target price on the stock.
Advertisement
Today there are 34,403,000 shares in issue of Venture Life Group Plc which are now trading at 52 which brings the business’s market capitalisation to 17.89M GBP. Numis Securities Ltd reissued a buy rating and set a GBX 400 ($5.22) target price on shares of Ocado Group PLC in a report on Tuesday, September 13th. Over the last 30 and 90 trading days the company share price has decreased 12.6 points and increased 41 points respectively. Royal Bank Of Canada upgraded shares of Imperial Tobacco Group PLC from an “underperform” rating to a “sector perform” rating in a research report on Friday, June 17th. Five research analysts have rated the stock with a sell rating, two have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company.
Panmure Gordon noted a target price of 128 on Venture Life Group Plc’s shares.
As of 14:27 BST, Imperial Tobacco’s share price had lost 1.96 percent to 3,928.50p, underperforming the broader London market, with the benchmark FTSE 100 index now standing 0.14 percent higher at 6,840.59 points. The stock has a market cap of $48.43 billion, a P/E ratio of 32.32 and a beta of 0.62. “The deep- discount segment’s share of the market is growing rapidly (which is lowering the average selling price) even before the “sticker shock” of moving to packs of 20 sticks and standardising packaging (by May 2017)”.
Advertisement
During the past year Venture Life Group Plc’s shares have decreased by -34.14% from 78.95 to 52. The shares were acquired at an average cost of GBX 227 ($2.96) per share, with a total value of £227,000 ($296,305.97). Its product range includes the UltraDEX oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers.
